Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $23.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price raised by research analysts at Wells Fargo & Company from $22.00 to $23.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target suggests a potential upside of 18.89% from the company’s current price.

Several other equities research analysts have also recently issued reports on the stock. Citizens Jmp boosted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Scotiabank upped their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “sector perform” rating in a research report on Thursday, May 21st. Cantor Fitzgerald upped their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Friday, May 1st. Finally, Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Monday, May 18th. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $22.40.

Sabra Healthcare REIT Trading Down 2.7%

Shares of SBRA stock traded down $0.55 during trading hours on Monday, reaching $19.35. 642,770 shares of the stock were exchanged, compared to its average volume of 2,481,440. Sabra Healthcare REIT has a 12-month low of $17.13 and a 12-month high of $21.28. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The company’s 50-day moving average price is $20.29 and its 200-day moving average price is $19.71. The firm has a market capitalization of $4.88 billion, a price-to-earnings ratio of 30.71, a price-to-earnings-growth ratio of 1.49 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT will post 1.51 earnings per share for the current year.

Institutional Trading of Sabra Healthcare REIT

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in Sabra Healthcare REIT by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock worth $671,045,000 after acquiring an additional 481,231 shares during the period. Principal Financial Group Inc. lifted its position in Sabra Healthcare REIT by 0.4% during the 1st quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock worth $481,755,000 after acquiring an additional 98,770 shares during the period. Nuveen LLC lifted its position in Sabra Healthcare REIT by 28.6% during the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after acquiring an additional 1,625,072 shares during the period. Geode Capital Management LLC lifted its position in Sabra Healthcare REIT by 2.9% during the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock worth $132,949,000 after acquiring an additional 198,118 shares during the period. Finally, Bank of America Corp DE lifted its position in Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after acquiring an additional 447,528 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.